Drug-induced kidney injury remains a significant concern in pharmaceutical development, with traditional methods often falling short in predicting renal toxicity across diverse compounds and patient populations. RENAsym is a quantitative systems toxicology (QST) platform used for mechanistic modeling of kidney injury, allowing researchers to predict, understand, and manage kidney safety concerns. Join us on October 16th to learn about the latest enhancements, including:

• New biological components: Discover the addition of podocyte and distal tubule models—key for simulating glomerular and tubular injury mechanisms.
• Improved crystal nephropathy modeling: Explore enhancements that provide more accurate simulation of crystal-associated renal damage.
• Novel biomarkers: Learn how new biomarker representations support early detection and mechanistic insight
• Real-world applications: Review novel predictions for compounds like lithium and polymyxin B, showcasing the power of QST in action.

There will be a live software demonstration and Q&A that you won’t want to miss, so register now to save your spot.

Presenter: 

•  Jeff Woodhead – Senior Principal Scientist, QSP

Moderator:

• Andrew Mueller – Director, Business Development